Clinical and genetic characteristics of 100 consecutive patients with Birt-Hogg-Dubé syndrome in Eastern Chinese region

• Published in: Orphanet journal of rare diseases 2024-09, Vol.19 (1), p.348-9, Article 348
• Main Authors: Hu, Daiju, Wang, Rui, Liu, Jinli, Chen, Xianmeng, Jiang, Xianliang, Xiao, Jun, Ryu, Jay H, Hu, Xiaowen
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; Birt-Hogg-Dube syndrome; Birt-Hogg-Dube Syndrome - epidemiology; Birt-Hogg-Dube Syndrome - genetics; Birt-Hogg-Dubé syndrome; China - epidemiology; Diagnosis; Diagnostic criteria; East Asian People; Female; FLCN mutation; Gene mutations; Genetic aspects; Humans; Male; Medical research; Medicine, Experimental; Middle Aged; Mutation - genetics; Pneumothorax - epidemiology; Pneumothorax - genetics; Proto-Oncogene Proteins - genetics; Retrospective Studies; Tumor Suppressor Proteins - genetics; Young Adult
• ISSN: 1750-1172; 1750-1172
• DOI: 10.1186/s13023-024-03360-1

Although an increasing number of patients with Birt-Hogg-Dubé syndrome (BHD) are being recognized in China, clinical and genetic characteristics are not well-defined. In addition, revised diagnostic criteria for the Chinese population was proposed in 2023, we aimed to explore their utility in clinical practice at a rare lung disease center. We retrospectively analyzed the data of 100 consecutive patients with BHD diagnosed according to the revised Chinese BHD criteria, encountered at the First Affiliated Hospital of University of Science and Technology of China from Jan 2017 to June 2023. There were 100 patients (including 63 females) from 65 unrelated families in Eastern China, mostly Anhui Province. The common manifestations were pulmonary cysts (99%), pneumothorax (60%), and skin lesions (77%). Renal cancer and renal angiomyolipoma were detected in 5 patients each. 37% of patients had no family history of BHD. In total, 25 FLCN germline mutations were detected, including 6 novel mutations. In addition to hotspot mutation c.1285delC/dupC (17%), the most common mutations were c.1015 C > T (16%), c.1579_1580insA (14%), and exons 1-3 deletion (11%) in FLCN. Higher risk of pneumothorax was associated with exons 1-3 deletion mutation and c.1177-5_1177-3de1CTC compared to the hotspot mutation c.1285dupC (91% [95% CI: 0.31, 46.82, p = 0.015] and 67% [95% CI: 0.35, 71.9, p = 0.302] vs. 30%, respectively). The average delay in diagnosis was 7.6 years after initial symptoms. Chinese diagnostic criteria were mostly consistent with typical pulmonary presentations with supportive genetic evidence. In the Eastern Chinese region, patients with BHD present most commonly with pulmonary cysts associated with pneumothorax and skin lesions. However, low incidence of renal cancer along with unexpected renal angiomyolipoma was observed. Genotypic spectrum differed from that reported from other global regions, and genotype association of pneumothorax warrants further research. The revised Chinese criteria for BHD seem more appropriate in diagnosing BHD in Chinese patients.